NDA 206481 describes TENOFOVIR DISOPROXIL FUMARATE, which is a drug marketed by
Aurobindo Pharma,
Casi Pharms Inc,
Chartwell,
Cipla,
Hetero Labs Ltd Iii,
Macleods Pharms Ltd,
Mylan,
Mylan Labs Ltd,
Qilu,
Reyoung,
Strides Pharma, and
Teva Pharms Usa, and is included in twelve NDAs. It is available from
fourteen suppliers. Additional details are available on the
TENOFOVIR DISOPROXIL FUMARATE profile page.
The generic ingredient in TENOFOVIR DISOPROXIL FUMARATE is
tenofovir disoproxil fumarate. There are forty-two
drug master file entries for this compound. Fifteen
suppliers are listed for this compound. Additional details are available on the
tenofovir disoproxil fumarate profile page.